Correction to: A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6–dependent B cell lymphomas (Nature Medicine, (2009), 15, 12, (1369-1376), 10.1038/nm.2059)

Leandro C. Cerchietti, Eloisi C. Lopes, Shao Ning Yang, Katerina Hatzi, Karen L. Bunting, Lucas A. Tsikitas, Alka Mallik, Ana I. Robles, Jennifer Walling, Lyuba Varticovski, Rita Shaknovich, Kapil N. Bhalla, Gabriela Chiosis, Ari Melnick

Research output: Contribution to journalComment/debatepeer-review

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/nm.2059, published online 22 November 2009. In the original published version of this article, the actin control shown in Fig. 3c (dose dependence in OCI-Ly7 cells) was incorrect. The correct control has been located and can been seen in Fig. 1 below. (Figure presented.).

Original languageEnglish (US)
JournalNature medicine
DOIs
StateAccepted/In press - 2024

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Correction to: A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6–dependent B cell lymphomas (Nature Medicine, (2009), 15, 12, (1369-1376), 10.1038/nm.2059)'. Together they form a unique fingerprint.

Cite this